1. Home
  2. NGL vs TBPH Comparison

NGL vs TBPH Comparison

Compare NGL & TBPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NGL
  • TBPH
  • Stock Information
  • Founded
  • NGL 1940
  • TBPH 2013
  • Country
  • NGL United States
  • TBPH United States
  • Employees
  • NGL N/A
  • TBPH N/A
  • Industry
  • NGL Natural Gas Distribution
  • TBPH Biotechnology: Pharmaceutical Preparations
  • Sector
  • NGL Utilities
  • TBPH Health Care
  • Exchange
  • NGL Nasdaq
  • TBPH Nasdaq
  • Market Cap
  • NGL 409.2M
  • TBPH 464.5M
  • IPO Year
  • NGL 2011
  • TBPH N/A
  • Fundamental
  • Price
  • NGL $3.37
  • TBPH $8.91
  • Analyst Decision
  • NGL
  • TBPH Buy
  • Analyst Count
  • NGL 0
  • TBPH 3
  • Target Price
  • NGL N/A
  • TBPH $11.33
  • AVG Volume (30 Days)
  • NGL 325.7K
  • TBPH 268.3K
  • Earning Date
  • NGL 05-29-2025
  • TBPH 05-08-2025
  • Dividend Yield
  • NGL N/A
  • TBPH N/A
  • EPS Growth
  • NGL N/A
  • TBPH N/A
  • EPS
  • NGL N/A
  • TBPH N/A
  • Revenue
  • NGL $5,918,601,000.00
  • TBPH $65,266,000.00
  • Revenue This Year
  • NGL N/A
  • TBPH $51.09
  • Revenue Next Year
  • NGL N/A
  • TBPH N/A
  • P/E Ratio
  • NGL N/A
  • TBPH N/A
  • Revenue Growth
  • NGL N/A
  • TBPH 6.11
  • 52 Week Low
  • NGL $2.64
  • TBPH $7.44
  • 52 Week High
  • NGL $6.08
  • TBPH $10.90
  • Technical
  • Relative Strength Index (RSI)
  • NGL 51.23
  • TBPH 40.95
  • Support Level
  • NGL $3.01
  • TBPH $8.69
  • Resistance Level
  • NGL $3.23
  • TBPH $10.55
  • Average True Range (ATR)
  • NGL 0.18
  • TBPH 0.38
  • MACD
  • NGL 0.09
  • TBPH -0.12
  • Stochastic Oscillator
  • NGL 90.38
  • TBPH 12.06

About NGL NGL ENERGY PARTNERS LP Common Units representing Limited Partner Interests

NGL Energy Partners LP is a USA-based firm that owns and operates a vertically integrated energy business. The company's operating segments include Crude Oil Logistics, Water Solutions, and Liquids Logistics. It operates crude oil Logistics, owns pipeline injection stations, and offers services for the treatment and disposal of wastewater generated from crude oil and natural gas production, and for the disposal of solids, such as tank bottoms and drilling fluids. The firm also supplies natural gas liquids to retailers, wholesalers, refiners, and petrochemical plants and sells propane and distillates.

About TBPH Theravance Biopharma Inc.

Theravance Biopharma Inc is a diversified biopharmaceutical company focused on the discovery, development, and commercialization of organ-selective medicines. Its purpose is to pioneer a new generation of small-molecule drugs designed to better meet patient needs. Its research is focused on the areas of inflammation and immunology. The firm applies organ-selective expertise to target disease biologically, to discover and develop medicines that may expand the therapeutic index with the goal of maximizing efficacy and limiting systemic side effects. The company develops lung-selective medicines to treat respiratory disease, including FDA-approved YUPELRI (revefenacin) inhalation solution indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD).

Share on Social Networks: